|

KT-621 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Kymera Therapeutics, Inc.2

Indications

  • Asthma2
  • Eosinophilic Asthma1
  • Asthma (Diagnosis)1

Lancaster, California1 trial

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Kymera Investigative Site

Phase 2

Tampa, Florida1 trial

A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study

Kymera Investigative Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.